A Prospective, Multicenter, Open-label, Comparative, Efficacy Study of Pegasys Plus Copegus in Treatment-naive Latino Patients With Chronic Hepatitis C-genotype 1, as Compared to Treatment-naive Non- Latino Caucasian Patients With Chronic Hepatitis C-genotype 1
Phase of Trial: Phase IV
Latest Information Update: 29 Jun 2016
At a glance
- Drugs Peginterferon alfa-2a; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms LATINO
- 01 Jun 2010 Actual end date changed from Mar 2006 to Feb 2008 as reported by ClinicalTrials.gov.
- 14 Jan 2009 Primary endpoint 'Sustained virological response rate' has been met.
- 14 Jan 2009 Results published in the New England Journal of Medicine, according to 1020878.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History